Morgan Petronelli
Assistant Managing Editor at Contemporary OB/GYN
Managing Editor of @contempPEDS and @ContempOBGYN | RTs/likes ≠ endorsements
Articles
-
Nov 28, 2024 |
contemporarypediatrics.com | Joshua Fitch |Morgan Petronelli
Gratitude can positively impact overall wellbeing, with studies increasingly highlighting its benefits, according to the American Academy of Pediatrics (AAP). Research indicates that practicing gratitude can improve physical, emotional, and mental health. To encourage gratitude in children, the AAP provides practical advice for parents, which can also be shared with patients’ families. These strategies aim to foster a mindset centered on learning and appreciation.
-
Nov 12, 2024 |
contemporaryobgyn.net | Morgan Petronelli
A study presented at IDWeek 2024 highlights the significant impact of Brazil's quadrivalent HPV vaccination (4vHPV) program on reducing hospitalizations for genital warts (GW) and high-grade cervical intraepithelial neoplasia (CIN2/3). Conducted by a team of researchers from MSD and Precision Data in São Paulo, this large-scale ecological retrospective study utilized data from the Brazilian National Hospital database (SIH), which covers 75% of the country's population.
-
Nov 11, 2024 |
contemporaryobgyn.net | Morgan Petronelli
At the IDWeek 2024 conference, a study from Panama has shed light on the potential public health impact of transitioning from a 4-valent (4vHPV) to a 9-valent human papillomavirus (9vHPV) vaccination program. The study highlights how expanding the national vaccination strategy to include 5 additional HPV genotypes could substantially reduce the incidence of HPV-related cancers and diseases over the next century.
-
Oct 25, 2024 |
contemporaryobgyn.net | Morgan Petronelli
Iterum Therapeutics has announced the FDA has approved the new drug application for ORLYNVAH (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections (uUTIs) caused by the microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis. ORLYNVAH is now approved for adult women with limited or no alternative oral antibacterial treatment options.
-
Oct 22, 2024 |
contemporarypediatrics.com | Morgan Petronelli
A study presented at IDWeek 2024 highlights the significant impact of Brazil's quadrivalent HPV vaccination (4vHPV) program on reducing hospitalizations for genital warts (GW) and high-grade cervical intraepithelial neoplasia (CIN2/3). Conducted by a team of researchers from MSD and Precision Data in São Paulo, this large-scale ecological retrospective study utilized data from the Brazilian National Hospital database (SIH), which covers 75% of the country's population.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 601
- Tweets
- 758
- DMs Open
- No
RT @ContempOBGYN: The FDA has accepted an #NewDrugApplication for elinzanetant, a drug by @Bayer for the management of #VasomotorSymptoms a…
RT @ContempOBGYN: A recent study from @MDAndersonNews found adding metronidazole to cefazolin before #GynecologicSurgery significantly redu…
RT @ContempOBGYN: A recent study shows a significant increase in term #birthweight since 1950. This trend, seen globally, highlights change…